Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366991439> ?p ?o ?g. }
- W4366991439 abstract "Abstract Outcomes for half of patients with melanoma remain poor despite standard-of-care checkpoint inhibitor therapies. The prevalence of the melanoma-associated antigen chondroitin sulfate proteoglycan 4 (CSPG4) expression is ~70%, therefore effective immunotherapies directed at CSPG4 could benefit many patients. Since IgE exerts potent immune-activating functions in tissues, we engineer a monoclonal IgE antibody with human constant domains recognizing CSPG4 to target melanoma. CSPG4 IgE binds to human melanomas including metastases, mediates tumoricidal antibody-dependent cellular cytotoxicity and stimulates human IgE Fc-receptor-expressing monocytes towards pro-inflammatory phenotypes. IgE demonstrates anti-tumor activity in human melanoma xenograft models engrafted with human effector cells and is associated with enhanced macrophage infiltration, enriched monocyte and macrophage gene signatures and pro-inflammatory signaling pathways in the tumor microenvironment. IgE prolongs the survival of patient-derived xenograft-bearing mice reconstituted with autologous immune cells. No ex vivo activation of basophils in patient blood is measured in the presence of CSPG4 IgE. Our findings support a promising IgE-based immunotherapy for melanoma." @default.
- W4366991439 created "2023-04-27" @default.
- W4366991439 creator A5008405554 @default.
- W4366991439 creator A5010500551 @default.
- W4366991439 creator A5010813520 @default.
- W4366991439 creator A5011616773 @default.
- W4366991439 creator A5014075850 @default.
- W4366991439 creator A5015311837 @default.
- W4366991439 creator A5017494077 @default.
- W4366991439 creator A5017656570 @default.
- W4366991439 creator A5019611893 @default.
- W4366991439 creator A5021192229 @default.
- W4366991439 creator A5023970121 @default.
- W4366991439 creator A5025344866 @default.
- W4366991439 creator A5025509088 @default.
- W4366991439 creator A5026699857 @default.
- W4366991439 creator A5031510758 @default.
- W4366991439 creator A5034748028 @default.
- W4366991439 creator A5034983939 @default.
- W4366991439 creator A5039081890 @default.
- W4366991439 creator A5039788948 @default.
- W4366991439 creator A5040841646 @default.
- W4366991439 creator A5041984199 @default.
- W4366991439 creator A5042058821 @default.
- W4366991439 creator A5047693717 @default.
- W4366991439 creator A5048384355 @default.
- W4366991439 creator A5055567663 @default.
- W4366991439 creator A5064339857 @default.
- W4366991439 creator A5065747962 @default.
- W4366991439 creator A5066668354 @default.
- W4366991439 creator A5069467875 @default.
- W4366991439 creator A5071903220 @default.
- W4366991439 creator A5072271516 @default.
- W4366991439 creator A5075225663 @default.
- W4366991439 creator A5076507299 @default.
- W4366991439 creator A5077762213 @default.
- W4366991439 creator A5079275321 @default.
- W4366991439 creator A5079712523 @default.
- W4366991439 creator A5080370646 @default.
- W4366991439 creator A5080433476 @default.
- W4366991439 creator A5084589458 @default.
- W4366991439 creator A5085001987 @default.
- W4366991439 date "2023-04-25" @default.
- W4366991439 modified "2023-10-12" @default.
- W4366991439 title "Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4" @default.
- W4366991439 cites W1535887975 @default.
- W4366991439 cites W1597852477 @default.
- W4366991439 cites W1904286143 @default.
- W4366991439 cites W1971977282 @default.
- W4366991439 cites W1980799332 @default.
- W4366991439 cites W1981422705 @default.
- W4366991439 cites W1982090512 @default.
- W4366991439 cites W1986204470 @default.
- W4366991439 cites W1986547754 @default.
- W4366991439 cites W1987474862 @default.
- W4366991439 cites W1990367169 @default.
- W4366991439 cites W1998121629 @default.
- W4366991439 cites W2003927412 @default.
- W4366991439 cites W2023095985 @default.
- W4366991439 cites W2025873030 @default.
- W4366991439 cites W2026104900 @default.
- W4366991439 cites W2035355788 @default.
- W4366991439 cites W2045341504 @default.
- W4366991439 cites W2057265591 @default.
- W4366991439 cites W2061355665 @default.
- W4366991439 cites W2068540199 @default.
- W4366991439 cites W2069346893 @default.
- W4366991439 cites W2073245859 @default.
- W4366991439 cites W2083408248 @default.
- W4366991439 cites W2084410433 @default.
- W4366991439 cites W2085990604 @default.
- W4366991439 cites W2119690983 @default.
- W4366991439 cites W2120259831 @default.
- W4366991439 cites W2130410032 @default.
- W4366991439 cites W2145290079 @default.
- W4366991439 cites W2146512944 @default.
- W4366991439 cites W2147233186 @default.
- W4366991439 cites W2149532361 @default.
- W4366991439 cites W2150032631 @default.
- W4366991439 cites W2154913159 @default.
- W4366991439 cites W2161335936 @default.
- W4366991439 cites W2221047364 @default.
- W4366991439 cites W2509822373 @default.
- W4366991439 cites W2577835345 @default.
- W4366991439 cites W2607129810 @default.
- W4366991439 cites W2614824762 @default.
- W4366991439 cites W2749613778 @default.
- W4366991439 cites W2767533179 @default.
- W4366991439 cites W2782689229 @default.
- W4366991439 cites W2783055842 @default.
- W4366991439 cites W2783594320 @default.
- W4366991439 cites W2787879256 @default.
- W4366991439 cites W2789600872 @default.
- W4366991439 cites W2796501719 @default.
- W4366991439 cites W2802078656 @default.
- W4366991439 cites W2883535107 @default.
- W4366991439 cites W2907549567 @default.
- W4366991439 cites W2930479061 @default.
- W4366991439 cites W2937915324 @default.
- W4366991439 cites W2966386794 @default.